Overexpression of the c-Met/hepatocyte growth factor receptor(HGF-R) proto-oncogene and abnormal generation of intracellular oxygen species (reactive oxygen species (ROS)) have been linked, by independent lines of evidence, to cell transformation and to malignant growth. By comparing two subpopulations of the B16 mouse melanoma (B16-F0 and B16-F10) endowed with different lung metastasis capacities (low and high, respectively) we found that both the expression/phosphorylation of c-Met and the steady-state levels of ROS positively correlated with metastatic growth. shRNA-mediated downregulation of c-Met in F10 cells led to a parallel decrease in the generation of oxygen species and in metastatic capacity, suggesting that oxidants may mediate the pro-metastatic activity of the HGF receptor. c-Met activation by a ligand elicits the formation of oxidant species through the oxidase-coupled small GTPase Rac-1, a relevant downstream target of the HGF-R. Moreover, cell treatment with the catalytic ROS scavengers EUK-134 and EUK-189 attenuates Met signaling to ERKs and inhibits the anchorage-independent growth of F10 cells, consistent with a critical role for oxygen species in HGF signaling and in aggressive cell behavior. Finally, genetic manipulation of the Rac-ROS cascade at different levels demonstrated its crucial role in the pro-metastatic activity of c-Met in vivo. Thus, we have outlined a novel cascade triggered by c-Met and mediated by ROS, linked to metastasis and potentially targetable by new antimetastatic, redox-based therapies.
Introduction
Molecular changes underlying the gain of metastatic capacity by malignant cells are still incompletely understood, and their identification represents an important avenue to the development of new, more effective antimetastatic therapies.
Since the seminal studies of Fidler and Kripke (1977) , demonstrating the pre-existence of clones endowed with different intrinsic metastatic capacities within a heterogeneous malignant population, the mouse melanoma B16 model has been extensively used to investigate the molecular circuitry involved in triggering the metastasic switch. Recently, this experimental model has been successfully exploited for the implementation and validation of a genomewide screen aimed at the identification/isolation of metastasis-associated genes (Clark et al., 2000) . One of the resulting candidate molecules, the Rho-family GTPase Rho-C, directly links metastatic growth to cytoskeleton dynamics and cell motility (Ridley, 2000) .
Among the genes whose causative role in invasive and metastatic cell growth has been thus far most convincingly demonstrated is the proto-oncogene c-Met, encoding the tyrosine kinase receptor of the hepatocyte growth factor/scatter factor Birchmeier et al., 2003; Corso et al., 2005) . In vitro and animal studies, as well as molecular analysis of human malignancies, in fact link abnormal activity of c-Met to malignant cell progression.
Although typical features of invasive growth, such as loss of polarity, increased motility, epithelial-mesenchymal transition and mitogenesis are easily induced in responsive cultured cells by HGF (Wells, 2000; Comoglio and Boccaccio, 2001) , deregulated HGF/c-Met signaling in transgenic mice leads to aberrant tissue development and to the genesis of histologically distinct neoplasms of both mesenchymal and epithelial origin, including melanomas (Takayama et al., 1997) , and to metastatic growth (Rong et al., 1994) . Finally, c-Met activation through either autocrine stimulation or receptor overexpression is a common finding in many human malignant tumors, especially in their advanced stages (http://www.vai.org/vari/metandcancer). Similar to many other growth factor RTKs, c-Met exerts its oncogenic potential through the deregulated activation of a number of protein phoshorylationdependent signaling cascades (Blume-Jensen and Hunter, 2001 ). These include the Grb-2/SOS/Ras pathway linked to cell proliferation and the PI3 Kinase/AkT pathway linked to cell survival and inhibition of apoptosis, but also a complex network of adaptors and transducers connecting c-Met to cytoskeleton dynamics, cell scattering and migration, cell adhesion and invasion Birchmeier et al., 2003) . The molecular organization of such complex motogenic activity requires the association of c-Met with both repulsive coreceptors, called Plexins , and adhesion molecules, like the a6b4 integrin (Comoglio et al., 2003) , and the coordinated modulation of the Rho family GTP-ases Rho, Rac and CDC42 (Royal et al., 2000) .
An emerging theme in signal transduction by growth factor receptors and adhesion molecules is the role of reactive oxygen species (ROS), and of hydrogen peroxide (H 2 O 2 ) in particular, as essential downstream intermediates that modulate cell responses through the transient and reversible oxidation of key intracellular signaling components (Finkel, 1998; Rhee et al., 2000) . In most cases, similar to the oxidative burst generated by bacterial ligands in activated phagocytes, growth factor-and integrin-triggered generation of ROS involves the membrane assembly of a NADPH-dependent oxidase complex, capable of transferring reducing equivalents to molecular oxygen, with the formation of superoxide anion (O 2 À ) (Lambeth, 2004) ; ligand-induced superoxide is subsequently dismutated to H 2 O 2 by the cytosolic, Cu-and Zn-dependent suproxide dismutase, also known as SOD1.
Key molecular components of the oxidase complex are cytochromes of the recently described Nox family, and the small GTPase Rac-1 (Lambeth, 2004) . The Rac/ ROS signaling module has been convincingly shown to contribute to mitogenic signaling by PDGF (Sundaresan et al., 1995) , EGF (Bae et al., 1997; Pani et al., 2000) , and VEGF (Colavitti et al., 2002) receptors and by oncogenic H-Ras (Irani et al., 1997; Liu et al., 2001) , and to have a role in the antiapoptotic cascade downstream of neurotrophin receptors (Bedogni et al., 2003) . Moreover, this signaling cassette is robustly activated by integrins upon cell-matrix interaction (Chiarugi et al., 2003; Nimnual et al., 2003) and is necessary for optimal focal adhesion assembly and for cell spreading of NIH-3T3 cells. In the current model, many of the above effects are mediated, at least in part, by the inhibitory effect of oxidant species on protein tyrosine phophatases on duty for restraining both the strength and the duration of growth factor and integrin signaling (Xu et al., 2002) . PTP1B (Lee et al., 1998) , SHP-2 (Meng et al., 2002) and the low molecular weight phosphatase (LMW-PTP) (Chiarugi et al., 2001 ) are among the enzymes for which the biochemical mechanism and the functional relevance of oxidative inactivation during redox signaling have been most convincingly demonstrated.
Although mitogenesis, survival and adhesion certainly require Rac/ROS-dependent signals, a specific role for the above redox pathway in the invasive and metastatic behavior of malignant cells has just started to be addressed (Radisky et al., 2005) , in spite of invasiveness recapitulating many cellular and molecular aspects of inflammatory processes, in which the involvement of this signaling cascade has been long established. On the other hand, it is conceivable that a redox signaling operates downstream of HGF/SF-R as is the case for many other RTK receptors; by extension, oxidant intermediates generated by Rac may specifically contribute to the pro-invasive and pro-metastatic behavior of malignancies in which c-Met signaling is deregulated.
The present work moved from our initial observation of overexpression of c-Met and elevated release of superoxide in a lung-specific (B16F 10 ) metastatic clone of the B16 mouse melanoma (Fidler and Nicolson, 1976) , and was designed to assess the potential role of the Rac-ROS pathway in the pro-metastatic signaling downstream of c-Met, within a well-established model of experimental metastasis.
Results
Overexpression of c-Met and elevated release of superoxide anion in a lung-specific clone of B16 melanoma cells Clones of the B16 murine melanoma with different metastatic capacities and tissue tropism have been originally derived and characterized by Fidler and coworkers (Fidler and Nicolson, 1976; Fidler and Kripke, 1977) . The B16 F10 clone forms metastatic colonies with high efficiency almost exclusively in the lungs following direct injection in the blood stream of syngeneic C57Bl6/ J mice ( Figure 1a) ; conversely, the original heterogeneous population B16F0 is poorly metastatic, in spite of the two populations having similar growth rates in vitro and when transplanted as subcutaneous tumors (Fidler, 1975; and our data not shown) .
In order to begin investigating the potential involvement of redox-modulated signaling cascades in the metastatic behavior of B16 cells, we assessed the release of superoxide anion by F0 and F10 cells, using a conventional NBT reduction test. After 1 h of incubation, cell staining by precipitated NBT was significantly more intense in F10 cells, indicating higher steady-state levels of superoxide ( Figure 1b) . As superoxide scavenging capacity is not different in the two cell lines, as suggested by the comparable expression of the two major superoxide dismutases (SOD1 and SOD2, Figure 1c ), the NBT reduction test indicates that an higher amount of superoxide is actively generated in metastatic F10 cells during the assay.
To establish a connection between generation of ROS and other potential upstream and downstream signaling events in B16 cells, the general patterns of protein tyrosine phoshorylation of F0 and F10 cells were also compared by antiphosphotyrosine immunoblot analysis of total protein lysates. Although tyrosine phosphorylation profiles appeared roughly very similar in the two cell lines, one prominent 145 kDa phosphoprotein was consistently scored in F10 cells stimulated by either fetal serum or fibronectin, which was much less pronunced in the corresponding F0 lysates ( Figure 1d , lanes 2, 4 and 6). Band isolation, followed by tandem (ion trap) mass spectrometry (see Materials and methods), led to the identification of p145 as the product of the murine c-Met proto-oncogene.
The identity of p145 as the HGF/SF receptor was further confirmed by anti-c-Met immunoprecipitation from F10 and F0 lysates, followed by either antiphosphotyrosine or anti-c-Met immunoblotting. This analysis revealed that c-Met protein levels are indeed markedly increased in F10 cells with respect to the F0 population (Figure 1e , middle panel) and that the protein is strongly phosphorylated on tyrosine residues in the former cell line (Figure 1e, upper panel) . As F10 cells (nor F0) do not produce significant amounts of HGF (data not shown), constitutive Met phosphorylation is likely due to overexpression (leading to spontaneous dimerization) of the receptor (Ponzetto et al., 1991) .
c-Met overexpression is necessary for the metastatic phenotype of B16F10 cells Increased activity of c-Met by overexpression, autocrine stimulation or mutation is a frequent finding in metastatic cancer (http://www.vai.org/vari/metandcancer). In the attempt to establish a causal link between elevated expression of the c-Met receptor, generation of oxygen species and metastatic capacity of the B16 F10 melanoma, cells were stably transduced with a lentiviral construct encoding either a Met-specific shRNA, or a scrambled shRNA as a control. In MetshRNA-transduced cells (Met-shRNA F10) both the immature 190 kDa precursor form and the mature 145 kDa form of the receptor were significantly reduced with respect to the scramble-transduced controls (ctrl-shRNA F10), as revealed by anti-c-Met immunoblot analysis (Figure 2A ). Importantly, expression levels so obtained were comparable to those observed in the poorly metastatic F0 line. In parallel with the amount of c-Met, steady-state generation of superoxide also was decreased in Met shRNA cells (Figure 2A, b) , indicating that deregulated c-Met activity may be directly responsible for abnormal generation of ROS in F10 cells.
When subjected to the experimental metastasis assay, Met-silenced cells formed a significantly lower number of large (>2 mm) lung colonies (16.279.5 versus 2.472.3 per mouse, Po0.05), compared to control cells overexpressing the HGF receptor, although with some variability among different animals ( Figure 2B ). This finding is in full agreement with a previous report of loss of invasiveness by Met-silenced cancer cells (Shinomiya et al., 2004) . As Met shRNA cells represent a polyclonal population, and metastases generated by Met-silenced cells were GFP-negative and positive for antiphospho-Met immunostaining (not shown), we assume that those colonies arose from cells which had escaped c-Met downregulation. Interestingly, intrinsic cell proliferative and survival capacity was not affected by the downregulation of c-Met, as indicated by the superimposable profiles of growth on plastic depicted in Figure 2C . These findings therefore indicate that elevated expression of c-Met is necessary to maintain both the prooxidant activity and the metastatic phenotype of B16F10 cells, whereas it is dispensable for cell proliferation in vitro.
Activation of the small GTPase Rac-1 by c-Met in B16 melanoma cells The HGF/SF receptor exerts its biological activities by coupling with a multiplicity of intracellular signaling components Birchmeier et al., 2003) including members of the Rho-like family of small GTPases. Among these G proteins, Rac-1 is part of the NADPH oxidase complex and is involved in the ligand-dependent generation of ROS (Pani et al., 2000; Colavitti et al., 2002) . Prompted by the above evidence linking c-Met expression to the generation of superoxide anion in B16 cells, we evaluated the activity of Rac-1 in the same set of cell lines. In F0 and F10 cells, GTP loading of Rac-1 (an indirect parameter for Rac activation) clearly correlated with high c-Met expression and with the cell metastatic capacity ( Figure 3A , a), being significantly higher in the F10 clone. Accumulation of Rac-GTP in F10 cells is not due to increased expression of the GTPase ( Figure 3A , a, lower panel), but rather reflects functional activation by one or more upstream signals. In both F0 and F10 populations, Rac GTP loading was further increased upon cell exposure to HGF, confirming the capacity of c-Met to activate this transducer ( Figure 3A , b). Moreover, in F10 and F0 cells engineered to express lower or higher amounts of c-Met, respectively, Rac activity mirrored the expression level of the HGF receptor ( Figure 3B and C). Taken together, these observations indicate that Rac-1 is a downstream target of c-Met in the B16 cell model, and by extension that the activity of this GTPase may have a role in determining the metastatic capacity of B16 cells.
Rac-1 couples c-Met to a redox-signaling cascade
The concomitance of c-Met overexpression, elevated activity of Rac-1 and increased release of superoxide in B16 F10 cells suggests that these three components may lie along the same oncogenic cascade. In order to further evaluate whether a redox-signaling circuitry operates downstream of the activated HGF/SF receptor, B16 cells were loaded with a cell-permeant fluorescent probe (dichlorofluorescein-diacetate (DCF-DA)) capable of detecting the intracellular release of peroxides (Pani et al., 2000) , and left untreated or stimulated with an exogenous hepatocyte growth factor. Cell fluorescence was then determined by flow cytometry. As indicated in Figure 4a , intracellular peroxides, in keeping with initial observations on the release of superoxide anion, are higher in F10 than in F0 cells. Unfortunately, a similar comparison could not be made between ctrlshRNA and Met-shRNA F10 cells, because of the constitutive, bright green fluorescence of these GFPtransduced cells.
Consistent with many reports on a variety growthfactor responsive cell systems (see Introduction), exposure of B16 cells to HGF elicits the ligand-dependent generation of intracellular peroxides, more evident in the F0 population (Figure 4a ), in a fashion that is clearly inhibited by overexpression of a Rac-1 dominantnegative mutant (RacV12N17, Figure 4b and relative insert). Thus, although with some limitations, these findings clearly imply that the intracellular content of peroxides (most likely H 2 O 2 ) in our cell model mirrors the expression/activity of c-Met, and is directly tuneable by HGF in a Rac-1-dependent manner.
To begin elucidating the signaling potential of c-Metdependent oxidant species, we first determined whether differences observed with the fluorescent probe corresponded to a different oxidation status of intracellular protein targets. To this end, protein lysates of untreated or HGF-stimulated F0 and F10 cells were immunoblotted with an antibody capable of detecting the formation of protein-glutathione adducts, a reliable marker of oxidative stress (Caplan et al., 2004) . As indicated in the panel of Figure 4c , cell content of glutathiolated proteins parallels the fluorimetric detection of ROS, being constitutively higher in c-Met overexpressing cells and further inducible by exogenous HGF. Cell exposure to the strong pro-oxidant diamide was used as a positive control for inducible protein glutathiolation.
Optimal activation of ERKs in response to many growth factors, including PDGF (Sundaresan et al., 1995) and VEGF (Colavitti et al., 2002) , requires the transient generation of ROS. To further evaluate the involvement of oxygen species in signal transduction by HGF/SF, we assessed the phosphorylation of ERKs in response to the factor, in antioxidant conditions. As shown in Figure 4d , c-Met coupling to ERKs was significantly blunted by removal of oxygen species (compare lane 4 with lanes 5 and 6), obtained by pre-incubating cells (B16 F0) with two different, highly effective superoxide/peroxide scavengers (Rong et al., 1999) . This finding suggests that ERK activation by c-Met requires ROS, at least in the present experimental system. Importantly, antioxidants neither compromised cell viability (not shown) nor affected the intracellular content of total ERKs (Figure 4d , lower panel).
As ERK activation by HGF is necessary for anchorage-independent cell growth (Zeng et al., 2002) , a hallmark of malignancy, we tested whether colony formation by F10 cells suspended in soft agar was also impaired by antioxidants. As indicated in Figure 4e , cell proliferation in agar was drastically reduced by both antioxidant compounds, already in the low micromolar range (20 mM). Although an effect of EUKs also on mitogenic signals independent of hepatocyte growth factor receptor (HGF-R) cannot be excluded in this experiment, the result, together with the phosphorylation studies depicted in Figure 4d , supports the role of ROS as critical intermediates in the pro-malignant cascade triggered by c-Met. In order to directly address the involvement of the Rac-ROS pathway in the metastatic behavior of B16F10 cells, a number of genetic manipulations were brought about with the scope of either disrupting or amplifying the above redox-signaling cascade.
In a current model (Figure 5B ), the weak oxidant superoxide, generated by Rac-dependent oxidases in response to growth factor stimulation, is efficiently converted into the stronger oxidant and signaling molecule H 2 O 2 , which in turn targets relevant intracellular transducers such as phosphatases and transcription factors (Lambeth, 2004) .
We blocked the Rac-ROS pathway either at an upstream level, by means of the Rac dominant-negative mutant RacV12N17 (Colavitti et al., 2002) , or by directly targeting H 2 O 2 via overexpression of its specific scavenger enzyme Catalase ( Figure 5A ). In both cases, cell manipulation lead to a significant and comparable decrease in cell metastatic capacity. Notably, a similar effect of Rac inhibition on experimental metastasis had already been reported in a similar model utilizing breast cancer cells (Bouzahzah et al., 2001) .
In a complementary approach, we overexpressed the copper/zinc-dependent superoxide dismutase, an H 2 O 2 -generating enzyme, with the aim of elevating the intracellular content of peroxide. As indicated in Figure  5A , a, this treatment substantially increased metastasis formation by B16F10 cells, in comparison to the mocktransfected control. Importantly, overexpression of SOD1 was nearly ineffective in F0 cells (not shown) but, somehow surprisingly, restored the metastatic capacity of Met-silenced F10 cells ( Figure 5A, b) . These findings, while underscore the potential pro-metastatic action of H 2 O 2 , suggest that peroxide may be not only necessary, but, at least in part, sufficient, if in the right cell context, to signal metastatic growth downstream of c-Met.
Discussion
The main findings of the present work can be summarized as follows: (a) Overexpression of c-Met plays a causative role in the metastatic behavior of a lung-specific clone derived from the B16 mouse melanoma. Deregulated activity of the HGF/SF receptors plays a pivotal role in the invasive and metastatic conversion of malignant cells, in both human and experimental settings. Here we provide evidence that overexpression of c-Met is necessary for the metastatic growth of a lung-specific variant of the B16 mouse melanoma. Involvement of c-Met in this popular model of experimental metastasis had not been investigated so far, with the exception of one study reporting c-Met overexpression in sublines selected for liver-specific metastatic capacity (Rusciano et al., 1995) . Although elevated expression of c-Met is required for B16F10 cells to colonize the lung, we have at the moment no evidence that this molecular event is sufficient to drive B16 metastatic growth. Preliminary experiments with F0 cells forced to overexpress c-Met ( Figure 3C ) failed to demonstrate increased metastatic capacity of this population to form lung metastases (not shown). One possible interpretation of this finding is that additional signaling changes are required for a fully metastatic phenotype in our model. Although we have excluded that this 'second signal' resides in autocrine secretion of HGF (data not shown), it is possible that the metastatic growth capacity, but not the homing specificity of F10 cells, relies on Met signaling. This possibility goes along with previous reports on the expression of lung-specific adhesion molecules on the surface of this cell subline (Zhu et al., 1991) . In support of the latter hypothesis is also the finding that metastatic capacity can be restored by overexpression of SOD1 only in Met-silenced F10, but not in non-metastatic F0 cells ( Figure 5A , b and data not shown). In this scenario, Met could be required for promoting tissue invasion and/or ectopic growth once cells have reached and bound the endothelium of the lung.
Although these points certainly need to be clarified, data presented strongly indicate that experimental lung metastases formation by B16F10 cells is overall a c-Metdependent process, and suggest, by extension, that this widely used model can be utilized for mechanistic studies on pro-metastatic signaling by the HGF/SF receptor.
Although activation of the small GTPase Rac-1 has already been reported as part of the motogenic program triggered by c-Met (Royal et al., 2000) , the possibility that the HGF/SF receptor couples to a Rac-dependent oxidative cascade had not been investigated so far. Racdependent redox signals have an established role not only in cell proliferation and survival (Joneson and BarSagi, 1998; Bedogni et al., 2003) , but also in adhesion, detachment and shape changes, secretion of metalloproteases and epithelial-mesenchimal transition (Kheradmand et al., 1998; Werner and Werb, 2002; Chiarugi et al., 2003; Radisky et al., 2005) , all responses integral to the invasive and metastatic behavior of malignant cells; activation of the Rac-ROS cascade by c-Met therefore appears to be biologically plausible. Interestingly, a redox-sensitive component has been recently identified in the signaling pathway triggered by plexins (Ventura and Pelicci, 2002) , a family of molecules known to associate and cooperate with c-Met during invasive growth . This component, named MICAL (for Molecule Interacting with CAS-Ligand), is necessary for semaphorin-induced neurite collapse in primary neurons, and harbors a B16F10 cells were transfected as desribed in Materials and methods with the indicated constructs, selected in puromycin and subjected to the experimental metastasis assay. Lung metastases were scored 3 weeks later. A significant reduction in the average number of metastases per mouse resulted either by inhibition of Rac activity (V12N17Rac) or by increased peroxide scavenging (Catalase), whereas overexpression of copper/zinc SOD markedly enhanced cell metastatic capacity. Data are mean7s.d. of lung metastases in individual mice (n ¼ 4/group). P-values were determined by subjecting the indicated paired populations to a directional Mann-Whitney rank test. Figure is representative of two independent experiments. (b) Effect of SOD1 overexpression on metastatic capacity of Met-silenced cells. Ctr-shRNA and Met-shRNA F10 cells were transiently transfected with the pEXV-SOD1 or the corresponding empty vector, and injected in mice as in (a). After 2 weeks, superficial lung metastases >2 mm were counted under the stereomicroscope. Regain of metastatic capacity by Metshrna cells overexpressing SOD1 was significant (Po0.05) by the directional Mann-Whitney rank test (n ¼ 6). The yeild of lung metastases was overall low in this particular experiment. (B) Flow-chart depicting a model for redox-signaling downstream of c-Met, and its impact on metastatic growth in light of the current knowledge and the results presented above. Experimental evidence points to a major role for hydrogen peroxide as a key pro-metastatic signaling molecule, likely through oxidative modifications of phosphatases, such as LMW-PTP, and transcription factors. Implications of this models are discussed in the text. c-Met signaling through reactive oxygen species D Ferraro et al FAD-binding domain suggestive of a potential involvement in electron exchange reactions (Terman et al., 2002) . This evidence further supports the notion that ROS and redox changes may have an important role in cell repulsion and scattering triggered by c-Met and its associated coreceptors. In this perspective, the possibility that generation of ROS triggered by HGF is mediated by Met-associated plexins and/or integrins is currently under investigation.
In line with the idea that oxidants participate in intracellular signaling by c-Met are also the inhibitory effects of antioxidant compounds on HGF-induced phosphorylation of ERK 1/2 and on anchorageindependent cell growth, as presented in Figure 4d and e. Although not directly addressed in this paper, it is conceivable that ROS signal to ERKs is mediated by the oxidative inhibition of one or more protein tyrosine phosphatases. In fact, several PTPs have been previously reported to associate with the HGF/SF receptors (VillaMoruzzi et al., 1998; Maroun et al., 2000; Palka et al., 2003) and to modulate its downstream signaling pathways. Moreover, preliminary evidence suggests physical association between c-Met and the low molecular weight protein tyrosine phoshatase (LMW-PTP; data not shown), an enzyme exquisitely sensitive to redox modulation by growth factors and integrins (Chiarugi et al., 2003; Nimnual et al., 2003) , and able to restrain ligand-dependent activation of MAP kinases (Chiarugi et al., 2003) .
In a simple model, inhibition of Met-specific PTPs by ROS generated in response to receptor activation may create a feed-forward loop that amplifies downstream oncogenic signaling. Along similar lines, PTP inactivation may mediate ligand-dependent transactivation of HGF-R by H 2 O 2 , as it was recently reported in tumor cells stimulated with EGF (Fischer et al., 2004) . These hypotheses still wait for experimental verification.
Experiments shown in Figure 5 clearly indicate that the integrity Rac-ROS signaling pathway is crucial in a cell model of lung-specific, Met-driven metastatic growth. Although the finding that Rac-1 blockade inhibits experimental metastasis is not completely surprising (Bouzahzah et al., 2001) , data on metastasis modulation by peroxide-producing (CuZnSOD) or -scavenging (Catalase) enzymes add novel information to the picture, directly implicating ROS and redox signaling in the metastatic process. In this respect, of particular interest is the evidence, presented in Figure  5A , b, of a regain of metastatic capacity by Met-shrna F10 cells overexpressing CuZn SOD, which suggests that peroxide could be able, at least in some circustances, to recapitulate the all pro-metastatic signal downstream of Met. It should be noted that both Met and intracellular superoxide are reduced but not eliminated in Met-silenced cells (Figure 2A, a and b) . In this context, increased conversion to superoxide by SOD overexpression may amplify residual Met signaling up to a critical threshold necessary for metastases to form. Alternatively, SOD1 may promiscously bring to metastatic potential other superoxide-generating oncogenes different from Met and normally insufficient to drive fully metastatic growth.
We can only speculate on the cellular mechanisms whereby, and the phase(s) of tumor dissemination at which ROSs exerts their pro-metastatic effects. We have recently shown that Trk-A triggered H 2 O 2 in PC12 cells prevents apoptosis by inducing activation of the cAMP responsive element binding protein (Bedogni et al., 2003) . Importantly, the closely related receptor Trk-B has been recently identified in a genomewide phenotypical screen as a metastasis determinant that prevents tumor cell anoikis in the very early phase of metastatic spreading (Douma et al., 2004) . Thus, ROS generated by c-Met may promote tumor cell survival in the bloodstream.
Alternatively, ROS may simply foster cell proliferation in established metastatic colonies, or contribute to cell adhesion-migration during extravasation. It is interesting to note that the Rac-ROS signaling module has also been implicated in oxygen sensing (Fu et al., 2000) , and may therefore have a specific role in directing circulating malignant cells towards the lungs along a chemotactic gradient of pO 2 .
It is at present difficult to sort among the above possibilities, in view of the fact that our experimental design, in which the number of visible, full-grown metastases is used as a read-out of cell metastatic potential, does not discriminate between differences in local cell growth and changes in cell capacity to reach and invade the target tissue. The fact that experiments shown in Figure 5A are made with transiently transfected populations and not with clones selected for stable protein expression may represent an initial hint of an early role of ROS-dependent signals during the establishment of metastasis. This issue clearly requires further and specific investigation.
Notwithstanding the above limitations, evidence that ROS directly contribute to Met-dependent metastatic growth opens a novel perspective in the complex correlation between oxygen radicals and malignancy, and suggest new possibilities of antioxidant-based therapeutic intervention, complementary to the search for Met-inhibitory compounds (Corso et al., 2005) .
Materials and methods

Animals
Male C57Bl6/J mice (6-8 weeks old ) were obtained from the animal facility of Universita' Cattolica del Sacro Cuore. Animals were maintained in temperature-controlled rooms with a 12 h light/dark cycle. All experimental procedures involving mice complied with the Guidelines of the Italian National Institute of Health, and were approved by the Institutional Ethical Committee.
Cell lines B16 F0 and B16 F10 mouse melanoma cell lines were obtained from the American Type Culture Collection (ATCC). Cells were routinely propagated in standard DMEM (4.5 g/l glucose) (Eurobio, France) containing 10% fetal calf serum (Sigma). 
Antibodies, reagents and plasmids
The following antibodies were used in the present study: antic-Met (rabbit polyclonal), antiphosphotyrosine (mouse monoclonal 4G10), and anti-SOD2 (rabbit polyclonal) from Upstate Biotechnology; anti-c-Met (mouse monoclonal), antiphospho-ERK (rabbit polyclonal), antitotal ERK (rabbit polyclonal), and anti-Rac-1 (mouse monoclonal) from Cell Signaling Technology; antiactin (goat polyclonal) and anti-myc-tag (mouse monoclonal 9E10) from Santa Cruz Biotechnology; anti-SOD1 (goat polyclonal) from Calbiochem; antiglutathione (mouse monoclonal) from Virogen; horseradish peroxidase (HRP)-conjugated goat anti-mouse antiserum from Amersham Pharmacia; HRP-conjugated goat anti-rabbit antiserum from Biorad. Chemicals and reagents were purchased from Sigma if not differently stated. The peroxide-sensitive fluorescent probe DCF-DA was from Molecular Probes. Glutathione-Sepharose 4B matrix for the purification of the GST-CRIB fusion protein was from Amersham Pharmacia.
The superoxide/peroxide catalytic scavengers EUK-134 and EUK-189 were kindly provided by Dr George Tocco (Eukarion Inc., MD, USA).
PEXV-based expression constructs for V12 (constitutively active) and V12N17 (dominant negative) Rac-1 were kindly provided by Dr A Hall (UCL London, UK); pLNX-Catalase was a gift from Dr Toren Finkel (National Institute of Health, Bethesda, USA). CuZnSOD-Neo was created by cloning a fulllength human SOD1 cDNA (ATCC) in the EcoRI site of the PcDNA3 expression vector (Invitrogen).
The Escherichia coli BL21 bacterial strain transformed with the IPTG-inducible GST-PAK-CD (PAK-CRIB domain) fusion protein was a generous gift from Dr J Collard (Amsterdam, the Netherlands).
Proteomics
Protein identification by tandem mass spectrometry was performed by ProtTech Inc. In brief, each protein gel band was in-gel digested with trypsin (Promega) and the resulting peptide mixture was subjected to tandem mass spectrometry. A Finnigan ion trap mass spectrometer LCQ coupled with a HPLC running a 75 mM ID C18 column was used. MS/MS spectra were used to search protein databases from GenBank with the ProtTech's ProtQuest software suite. The output from database search was manually analysed and validated by ProtTech scientists.
Cell transfection B16 cells (150 000 in six-well plate) were cotransfected with 0.8 mg of each expression construct and 0.2 mg of pBabe/puro, using the EFFECTENE reagent (Quiagen) according to the manufacturer's recommendations. Transfection efficiency was routinely of 75-85% based on cell fluorescence following transfection of a CMV-EGFP expression construct (PROMEGA). This percentage was further increased by a 48 h selection in 2.5 mg/ml puromycin.
Colony formation assay in soft agar. Cells were resuspended at low density (5000 cells/ml/10 cm 2 ) in complete medium containing 0.3% agarose and seeded in six-well plate on top of a solid layer of complete medium/0.6% agarose. Antioxidants , where necessary, were present from the beginning of the assay in both the lower and the upper agarose layer. Colony formation was assessed and colonies photographed 2 weeks later under the phase-contrast microscope.
Experimental metastasis assay Mice (6-8 weeks old) were injected in the tail vein with 150 000 B16 cells in 200 ml of saline. Mice were killed 2-3 weeks later, dissected and carefully inspected for the presence of black metastatic foci throughout the body. Lungs were removed and macroscopic colonies (>2 mm) counted under the stereomicroscope by two of the authors.
Measurement of ROS
Release of superoxide anion by adherent cells was quantified by a standard nitro-blue tetrazolium (NBT) reduction test, as described (Chiarugi et al., 2003) . Briefly, cells (100 000/cm 2 ) were incubated in Hank's balanced salt solution (HBSS) containing 2 mg/ml NBT (Sigma). After 2 h at 371C, supernatants were removed and cells lysed in isopropanol/0.04 M HCl. Following low-speed centrifugation, pellets were dissolved in pyridine at 1001C, and the absorbance at 570 nm quantified by an ELISA plate reader (Biorad). Intracellular peroxides were assessed by loading cells with DCF-DA (20 mg/ml for 10 min) in HBSS (Pani et al., 2000) . Mean green cell fluorescence (FL-1) was then determined by flow cytometry, using a COULTER flow cytometry equipped with a 488 nm Argon laser lamp.
Rac-1 activity assay Rac GTP loading was evaluated according to Sander (Sander et al., 1998) . Briefly, GTP-loaded Rac-1 was pulled down from total protein lysates using a Sepharose-bound GST-PAK-CRIB fusion protein. Washed precipitates were boiled, subjected to SDS-PAGE, transferred onto nitrocellulose and quantified by anti-Rac-1 immunoblotting.
Quantification of HGF in cell supernatants HGF secretion by B16 (F0 and F10) cells was evaluated on serum-free cell supernatants, 48 h after medium replacement, using the AN'ALYZA Immunoassay kit (TECHNE) according to the manufacturer's recommendations. Fresh serum-free medium and medium conditioned by the HGFproducing MRC-5 cell line (human embryonic fibroblasts) were included in the analysis as negative and positive controls, respectively.
Miscellaneous
Cell lysis, immunopecipitations and Western blotting were performed according to standard procedures (Pani et al., 2000) . For the evaluation of protein-glutathione adducts, cells were lysed in the presence of the thiol blocking reagent N-ethyl maleimide (NEM, 50 mM, Sigma), in order to avoid post-lysis oxidations.
Statistics
Pairs of data sets were compared by directional MannWhitney rank test, where indicated. This non-parametric alternative to Student's t-test was preferred in view of the high variability and the non-normal distribution of values c-Met signaling through reactive oxygen species D Ferraro et al within samples. The threshold of significance was set at a value of Po0.05. Calculations were performed with the webbased VassarStats Software (http://faculty.vassar.edu/lowry/ webtext.html).
Abbreviations HGF-R, hepatocyte growth factor receptor; ROS, reactive oxygen species.
